Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease

被引：59

作者：

Yates S.C. ^{[1
]}

Zafar A. ^{[1
]}

Hubbard P. ^{[1
]}

Nagy S. ^{[1
]}

Durant S. ^{[2
]}

Bicknell R. ^{[2
]}

Wilcock G. ^{[3
]}

Christie S. ^{[3
]}

Esiri M.M. ^{[4
]}

Smith A.D. ^{[5
]}

Nagy Z. ^{[1
]}

机构：

[1] University of Birmingham, Neuropharmacology and Neurobiology, College of Medical and Dental Sciences, School of Clinical and Experimental Medicine, Birmingham

[2] University of Birmingham, Institute of Biomedical Research, College of Medical and Dental Sciences, Birmingham

[3] OPTIMA, University of Oxford, Level 4, John Radcliffe Hospital, Oxford

[4] University of Oxford, Level 1, John Radcliffe Hospital, Department of Neuropathology, Oxford

[5] University of Oxford, Department of Pharmacology, Mansfield Road, Oxford

来源：

Acta Neuropathologica Communications | / 1卷 / 1期

关键词：

Alzheimer's disease; ApoE; Cell cycle; MTOR; Risk factor;

D O I：

10.1186/2051-5960-1-3

中图分类号：

学科分类号：

摘要：

Background: The development of disease-modifying therapies for Alzheimer's disease is hampered by our lack of understanding of the early pathogenic mechanisms and the lack of early biomarkers and risk factors. We have documented the expression pattern of mTOR regulated genes in the frontal cortex of Alzheimer's disease patients. We have also examined the functional integrity of mTOR signaling in peripheral lymphocytes in Alzheimer's disease patients relative to healthy controls. Results: In the brain mTOR is seen to control molecular functions related to cell cycle regulation, cell death and several metabolic pathways. These downstream elements of the mTOR signaling cascade are deregulated in the brain of Alzheimer's disease patients well before the development of pathology. This dysregulation of the mTOR downstream signaling cascade is not restricted to the brain but appears to be systemic and can be detected in peripheral lymphocytes as a reduced Rapamycin response. Conclusions: The dysfunction of the signaling pathways downstream of mTOR may represent a risk factor for Alzheimer's disease and is independent of the ApoE status of the patients. We have also identified the molecular substrates of the beneficial effects of Rapamycin on the nervous system. We believe that these results can further inform the development of clinical predictive tests for the risk of Alzheimer's disease in patients with mild cognitive impairment. © 2013 Yates et al.; licensee BioMed Central Ltd.

引用

共 47 条

[1]

Fjell A.M., Walhovd K.B., Neuroimaging results impose new views on Alzheimer's disease-the role of amyloid revised, Mol Neurobiol, 45, pp. 153-172, (2012)

[2]

Reitz C., Alzheimer's disease and the amyloid cascade hypothesis: a critical review, Int J Alzheimers Dis, 2012, (2012)

[3]

Arendt T., Bruckner M.K., Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity, Biochim Biophys Acta, 1772, pp. 413-421, (2007)

[4]

Nagy Z., Esiri M.M., Smith A.D., The cell division cycle and the pathophysiology of Alzheimer's disease, Neuroscience, 87, pp. 731-739, (1998)

[5]

Arendt T., Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization, Neuroscience, 102, pp. 723-765, (2001)

[6]

Arendt T., Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity, Prog Neurobiol, 71, pp. 83-248, (2003)

[7]

Nagy Z., The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease, J Cell Mol Med, 9, pp. 531-541, (2005)

[8]

Gibbons J.J., Abraham R.T., Yu K., Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth, Semin Oncol, 36, pp. S3-S17, (2009)

[9]

Ma X.M., Blenis J., Molecular mechanisms of mTOR-mediated translational control, Nat Rev Mol Cell Biol, 10, pp. 18-307, (2009)

[10]

Hoeffer C.A., Klann E., mTOR signaling: at the crossroads of plasticity, memory and disease, Trends Neurosci, 33, pp. 67-75, (2010)

← 1 2 3 4 5 →